Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Nat Prod Rep. 2020 Feb 18;37(5):717–736. doi: 10.1039/c9np00066f

Figure 8. Structures of SERCA inhibitors (thapsigargin and its prodrug mipsagargin, and basiliolide A1) and the K+ ionophore valinomycin as indirect modulators of secretory capacity though cation import regulation.

Figure 8.

Structural differences between thapsigargin and mipsagargin are indicated in blue.